Investors sold shares of Bristol-Myers Squibb (NYSE:BMY) on strength during trading on Wednesday following insider selling activity, AnalystRatings.Net reports. $38.72 million flowed into the stock on the tick-up and $57.65 million flowed out of the stock ... · 54 minutes ago
Bristol Myers Squibb
Bristol-Myers Squibb (NYSE:BMY)‘s stock had its “outperform” rating restated by analysts at William Blair in a report issued on Tuesday, Marketbeat reports. The analysts wrote, “Early Approval of Opdivo in Renal …
Ticker Report · 23 hours ago
Bristol Myers Squibb
In-depth coverage >
Bristol-Myers Squibb Company (BMY - Analyst Report) announced that the FDA has cleared its intravenous human programmed death receptor-1 (PD-1) blocking antibody, Opdivo, for the treatment of patients with BRAF V600 wild-type unresectable or …
ZACKS · 4 hours ago
metastatic melanoma
More from Bing News
Read more on this. Bristol-Myers Squibb Company (BMY), currently valued at $112.71B, opened at $67.63. A quick look at the market, the company’s stock traded between $67.24 and $67.95 with its 52-week range …
Jutia Group · 1 day ago
skin cancer
BMY closed Monday's trading at $67.99 ... XBIT closed Monday's trading at $13.25, down 2.14%. In after hours, the stock was down another 32.08% to $9.00.
NASDAQ · 1 day ago
For the first time ever, we are winning the battle against cancer. More people are living for years — instead of a few months — after being diagnosed with some of the deadliest forms of cancer. This includes melanoma …
Uncommon Wisdom Daily · 11/12/2015
Bristol Myers
Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report BRISTOL-MYERS (BMY): Free Stock Analysis Report BIOGEN INC (BIIB): Free Stock Analysis Report MERCK & CO INC (MRK): Free Stock Analysis Report
Yahoo Finance · 1 day ago
Renal Cell Cancer
Therefore, I would not buy Bristol-Myers at current levels, but rather wait for a reaction in the stock price and have another look at that point. Bristol-Myers Squibb has a long and proud history of producing shareholder value. For many years, the ...
Seeking Alpha · 11/17/2015
Bristol Myers
So what: Aduro BioTech is working with some of the globe's biggest drugmakers, including Bristol-Myers Squibb (NYSE ... And we think its stock price has nearly unlimited room to run for early in-the-know investors! To be one of them, just click here.
The Motley Fool · 1 day ago
Aduro BioTech
The stock has an 89 Composite Rating and is trading a little above its 154.84 cup-with-handle entry. Bristol-Myers Squibb (NYSE:BMY) is another health care name in which the fund began a position in Q3. Kelly likes …
Investors Business Daily · ByPaul Katzeff · 11/19/2015
mutual fund
Bristol-Myers (BMY) announced the FDA has approved Opdivo for treating ... J.M. Smucker (SJM) announced a selling shareholder will offer 2.86 million shares of its common stock in a secondary offering. Brocade …
Realtime Business News · 10 hours ago
Market Analysis

Bristol-Myers Squibb

Bristol-Myers Squibb, often referred to as BMS, is an American pharmaceutical company, headquartered in New York City. Bristol-M…
Bristol-Myers Squibb, often referred to as BMS, is an American pharmaceutical company, headquartered in New York City. Bristol-Myers Squibb manufactures prescription pharmaceuticals in several therapeutic areas, including cancer, HIV/AIDS, cardiovascular disease, diabetes, hepatitis, rheumatoid arthritis and psychiatric disorders. Its mission is to "discover, develop and deliver innovative medicines that help patients prevail over serious diseases."
Data from: Wikipedia · Freebase